Literature DB >> 29742946

Comparative analysis of osseointegration in various types of acetabular implant materials.

Stanislav Bondarenko1, Ninel Dedukh1, Volodymyr Filipenko1, Mandus Akonjom1, Ahmed Amine Badnaoui1, Ran Schwarzkopf2.   

Abstract

BACKGROUND: There is a lack of comparative data on osseointegration (BIC) of acetabular cup surfaces in hip arthroplasty in both normal bone mineral density and in conditions of osteoporosis. AIM: To compare osseointegration of acetabular implants with various types of surfaces in an animal model with normal and osteoporotic bone tissue.
MATERIAL AND METHODS: The study was performed on 60 rats. To simulate osteoporosis ovariectomy was performed in 30 animals. Thirty healthy rats served as controls. In standardised defects of the distal metadiaphysis of the femur we implanted: porous tantalum Trabecular Metal (A), Trabecular Titanium (B), Titanium with Gription coating (C), Stiktite (D), and Tritanum (E). Bone apposition (osseointegration) was defined as all areas of direct "bone-to-implant contact" (BIC).
RESULTS: No qualitative morphological differences in the evaluation of BIC around different implant types was seen in normal rats and rats with osteoporosis. Connective tissue areas around implants were larger in rats with osteoporosis. Morphometric studies showed that the highest BIC were seen in implants A and B, both in healthy animals ([72.00 ± 3.48]% and [67.46 ± 1.69]%) and ones with osteoporosis ([59.19 ± 2.10]% and [53.36 ± 2.57]%). BIC was (60.10 ± 2.05)%, (60.26 ± 2.36)%, and (61.78 ± 2.27)% around implants C, D and E in healthy rats, respectively. BIC in osteoporosis was (45.39 ± 2.37)%, (47.81 ± 2.41)% and (42.10 ± 1.44)%, respectively.
CONCLUSION: Our study showed that the evaluated implants have good BIC features. Furthermore, based on histomorthometry and histology, Porous tantalum Trabecular Metal (A) and Trabecular Titanium (B) implants exhibit higher BIC with bone tissue.

Entities:  

Keywords:  Acetabular implants; Bone-to-implant contact; Morphology; Rats; Trabecular Tantalum; Trabecular Titanium

Mesh:

Substances:

Year:  2018        PMID: 29742946     DOI: 10.1177/1120700018759314

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  5 in total

1.  Minimum 2-Year Outcomes of a Novel 3D-printed Fully Porous Titanium Acetabular Shell in Revision Total Hip Arthroplasty.

Authors:  Elyse J Berlinberg; J Abraham Kavian; Mackenzie A Roof; Ittai Shichman; Brett Frykberg; William B Lutes; Erik A Schnaser; Stephen A Jones; Richard W McCalden; Ran Schwarzkopf
Journal:  Arthroplast Today       Date:  2022-10-12

2.  Biocompatibility and Osseointegration of Calcium Phosphate-Coated and Non-Coated Titanium Implants with Various Porosities.

Authors:  A A Korytkin; N Yu Orlinskaya; Ya S Novikova; S A Gerasimov; D V Davydenko; K V Kulakova; S I Tverdokhlebov; E N Bolbasov
Journal:  Sovrem Tekhnologii Med       Date:  2021-01-01

3.  Comparison of early migration patterns between a ceramic and polyethylene liner in uncemented Trabecular Titanium cups: a 2-year randomized controlled trial of 52 hips using radiostereometric analysis.

Authors:  Amanda D Klaassen; Elisabeth A Schäffer; Nienke W Willigenburg; Loes W A H Van Beers; Vanessa A B Scholtes; Victor P M Van der Hulst; Lennard A Koster; Bart L Kaptein; Dirk Jan F Moojen; Rudolf W Poolman
Journal:  Acta Orthop       Date:  2022-04-28       Impact factor: 3.925

4.  Evaluation of the bone morphology around four types of porous metal implants placed in distal femur of ovariectomized rats.

Authors:  Stanislav Bondarenko; Nataliya Ashukina; Valentyna Maltseva; Gennadiy Ivanov; Ahmed Amine Badnaoui; Ran Schwarzkopf
Journal:  J Orthop Surg Res       Date:  2020-08-03       Impact factor: 2.359

5.  Comparison of the Primary Stability of Porous Tantalum and Titanium Acetabular Revision Constructs.

Authors:  Nicholas A Beckmann; Rudi G Bitsch; Mareike Schonhoff; Klaus-Arno Siebenrock; Martin Schwarze; Sebastian Jaeger
Journal:  Materials (Basel)       Date:  2020-04-10       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.